BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 15751497)

  • 1. Therapeutic options in the management of colon cancer: 2005 update.
    Wilkes GM
    Clin J Oncol Nurs; 2005 Feb; 9(1):31-44. PubMed ID: 15751497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current stage-specific chemotherapeutic options in colon cancer.
    Martin MJ
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):695-704. PubMed ID: 16111469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of metastatic colorectal cancer.
    Prescrire Int; 2010 Oct; 19(109):219-24. PubMed ID: 21180382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colon cancer: what is new in 2004?].
    André T; Louvet C; de Gramont A
    Bull Cancer; 2004 Jan; 91(1):75-80. PubMed ID: 14975808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on treatment advances for the first-line therapy of metastatic colorectal cancer.
    Lee JJ; Chu E
    Cancer J; 2007; 13(5):276-81. PubMed ID: 17921724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic options in colon cancer: focus on oxaliplatin.
    Wilkes GM
    Clin J Oncol Nurs; 2002; 6(3):131-7. PubMed ID: 11998605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New systemic frontline treatment for metastatic colorectal carcinoma.
    Braun AH; Achterrath W; Wilke H; Vanhoefer U; Harstrick A; Preusser P
    Cancer; 2004 Apr; 100(8):1558-77. PubMed ID: 15073842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant therapy of colon cancer: current status and future directions.
    Chung KY; Saltz LB
    Cancer J; 2007; 13(3):192-7. PubMed ID: 17620769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin in the treatment of colorectal cancer.
    Kim GP; Erlichman C
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):281-94. PubMed ID: 17428157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for localised colon cancer. Fluorouracil + folinic acid for node-positive, non-metastatic disease.
    Prescrire Int; 2011 Feb; 20(113):46-9. PubMed ID: 21488594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted agents for adjuvant therapy of colon cancer.
    de Gramont A; Tournigand C; André T; Larsen AK; Louvet C
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S42-5. PubMed ID: 17178286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of colonic carcinoma in the year 2001].
    Mross K; Semsek D
    Praxis (Bern 1994); 2001 Mar; 90(12):497-510. PubMed ID: 11324309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab: new drug. Metastatic colorectal cancer: good in theory, not in practice.
    Prescrire Int; 2006 Jun; 15(83):94-7. PubMed ID: 16764097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy for metastatic colorectal cancer].
    Iwasa S; Shimada Y
    Gan To Kagaku Ryoho; 2008 Sep; 35(9):1467-74. PubMed ID: 18799899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irinotecan fluorouracil plus leucovorin is not superior to fluorouracil plus leucovorin alone as adjuvant treatment for stage III colon cancer: results of CALGB 89803.
    Saltz LB; Niedzwiecki D; Hollis D; Goldberg RM; Hantel A; Thomas JP; Fields AL; Mayer RJ
    J Clin Oncol; 2007 Aug; 25(23):3456-61. PubMed ID: 17687149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 5-fluorouracil adjuvant treatment of colon cancer.
    Kelder W; Hospers GA; Plukker JT
    Expert Rev Anticancer Ther; 2006 May; 6(5):785-94. PubMed ID: 16759168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First- and second-line therapy of metastatic colorectal cancer.
    Terstriep S; Grothey A
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):921-30. PubMed ID: 16761936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
    Land SR; Kopec JA; Cecchini RS; Ganz PA; Wieand HS; Colangelo LH; Murphy K; Kuebler JP; Seay TE; Needles BM; Bearden JD; Colman LK; Lanier KS; Pajon ER; Cella D; Smith RE; O'Connell MJ; Costantino JP; Wolmark N
    J Clin Oncol; 2007 Jun; 25(16):2205-11. PubMed ID: 17470850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of colorectal carcinoma].
    Ulrich-Pur H; Jech B; Scheithauer W; Kornek GV; Huber H
    Wien Klin Wochenschr; 2002 Jun; 114(10-11):368-76. PubMed ID: 12708089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and challenges in the adjuvant treatment of stage II and III colon cancers.
    Chua YJ; Zalcberg JR
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):595-604. PubMed ID: 18402526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.